Latest / Pharmacy Podcast Network / Changing the Game: How Pediatric Pharmacists Enhanced My Medical Practice | Pediatric Pharmacist Review
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 0:26Speaker 2: Adverse drug reactions or ADRs, are a serious issue in
- 0:30Speaker 2: healthcare today. The pharmacist is the last line of defense
- 0:33Speaker 2: to help prevent ADRs. A rising role of the pharmacist
- 0:37Speaker 2: is the specialist who focuses on our children. Pediatric pharmacy
- 0:41Speaker 2: ensures safe and effective drug use and optimal medication therapy
- 0:45Speaker 2: outcomes and children up to eighteen years of age. Currently,
- 0:48Speaker 2: there are more than one four and fifty board certified
- 0:52Speaker 2: pediatric pharmacy specialists known as bps. If you're interested in
- 0:56Speaker 2: this expanding field of pharmacy, this podcast is for you.
- 1:00Speaker 2: All Right, everyone, let's give it up for our host.
- 1:04Speaker 3: Welcome back to the Pediatric Pharmacist Review. I am one
- 1:07Speaker 3: of your hosts, Justin Cole from Cedarville University and the
- 1:10Speaker 3: Center for Pharmacy Innovation. Here today, Jenna is not able
- 1:14Speaker 3: to join us as a co host, so we've got
- 1:16Speaker 3: Mary back this week. So Mary, thanks for joining me
- 1:19Speaker 3: to host this episode.
- 1:21Speaker 4: Thanks for having me Justin.
- 1:23Speaker 3: Oh yeah, this is getting to be a regular occurrence,
- 1:25Speaker 3: so I'm looking forward to continuing to have you here
- 1:27Speaker 3: on the podcast. Our guest today is doctor Amanda Weber.
- 1:31Speaker 3: She is a pediatric epileptologist at Nationwide Children's Hospital in Columbus, Ohio.
- 1:36Speaker 3: And I don't know how much this will come up
- 1:39Speaker 3: over time, but wow, a decade and a half ago, Amanda,
- 1:42Speaker 3: we actually got to work together, which was which was
- 1:45Speaker 3: a blast. So we're excited to have you on the
- 1:47Speaker 3: podcast today. What we're trying to do is simply understand
- 1:51Speaker 3: a physicians perspective on having pediatric pharmacists on your clinical
- 1:57Speaker 3: team as collaborators. So we really are excited to hear
- 2:00Speaker 3: from you and your experiences and learn a bit from you.
- 2:03Speaker 3: So thanks for joining us, Amanda.
- 2:04Speaker 5: Thanks so much for inviting me. I'm excited to be here.
- 2:08Speaker 4: Yeah.
- 2:08Speaker 3: All right, well I want to turn it over to
- 2:10Speaker 3: you and just maybe allow you to tell us a
- 2:13Speaker 3: bit more about your own training and your own background
- 2:17Speaker 3: and some of the things you get to do there
- 2:18Speaker 3: at Nation of White Children's.
- 2:20Speaker 6: Okay, So I did all of my training at Nation
- 2:23Speaker 6: My Children's Hospitals, starting from residency, and we had a
- 2:28Speaker 6: clinical pharmacist kind of integrated into multiple teams from the
- 2:32Speaker 6: very beginning, so we had ones that I specifically remember
- 2:37Speaker 6: were clinical pharmacists who participated in rounds in the infectious.
- 2:42Speaker 5: Disease ward in the ICUs.
- 2:45Speaker 6: And then of course once I moved on to neurology
- 2:47Speaker 6: residency and fellowship, we had very active participation with our
- 2:52Speaker 6: clinical pharmacists in our complex epilepsy clinics and just really
- 2:57Speaker 6: available to us kind of along the way as we
- 3:01Speaker 6: were learning different medications, medication interactions, and also to help
- 3:06Speaker 6: troubleshoot patient concerns if there were specific issues with patients
- 3:12Speaker 6: taking certain medications and things like that. So all along
- 3:16Speaker 6: through training we have had a pretty strong source of
- 3:21Speaker 6: support from clinical pharmacy, which I really appreciated.
- 3:25Speaker 4: I feel like we went hand in hand with that.
- 3:28Speaker 4: Like I really appreciated having the MD so close to
- 3:31Speaker 4: me as a resident, because I started off like also
- 3:34Speaker 4: as a pediatric pharmacy resident, and then I kind of
- 3:37Speaker 4: became friends with the pediatric medical residents and from there
- 3:40Speaker 4: we grew together. They became attendings, I became the pharmacist
- 3:43Speaker 4: on the unit, and then it just became such a
- 3:45Speaker 4: nice environment and I totally remember that. So absolutely you
- 3:51Speaker 4: had a pediatric pharmacist on your care team and residency.
- 3:55Speaker 4: In what capacity did they practice? Did they attend rounds?
- 3:58Speaker 4: Answer questions, was their collaborative this agreement?
- 4:02Speaker 6: Yes, so they attended rounds, especially in the ICU, and
- 4:07Speaker 6: then they were also kind of available behind the scenes
- 4:10Speaker 6: to help get medications covered and prior authorizations done, and
- 4:14Speaker 6: to help double check dosing and all those sorts of things.
- 4:22Speaker 3: Now, Amanda, I know that you practice in complex epilepsy
- 4:26Speaker 3: as well, so I would love to hear a little
- 4:29Speaker 3: bit more about that particular clinic and the interprofessional nature
- 4:32Speaker 3: of how you approach treating kids and working with families
- 4:37Speaker 3: when they have often genetic epilepsies or very complex epilepsy disorders.
- 4:43Speaker 6: Yeah, that's a great question. So our complex epilepsy clinic
- 4:49Speaker 6: is really multidisciplinary. It has the epileptologists, it has neuropsychologists,
- 4:56Speaker 6: they're genetic counselors, psychologists, neuropsychologists, clin pharmacy, and so everybody
- 5:02Speaker 6: comes together on the day of this clinic to help
- 5:06Speaker 6: address a patient, each patient in a really multidisciplinary way
- 5:11Speaker 6: and to assess kind of what their struggles and needs are.
- 5:14Speaker 6: And so you're right, there are a lot of patients
- 5:16Speaker 6: with complex genetic conditions who require pretty specialized medications and
- 5:24Speaker 6: have really a lot of healthcare needs and pretty complex
- 5:28Speaker 6: needs across many different specialties, and so it's really helpful
- 5:33Speaker 6: to have pharmacy there for a couple of reasons. You know,
- 5:37Speaker 6: a lot of times these patients are on multiple different
- 5:39Speaker 6: medications from multiple different subspecialties, and so just having the
- 5:44Speaker 6: pharmacy it's very involved in looking at medication interactions and
- 5:49Speaker 6: how we should modify dosing related to other medications that
- 5:54Speaker 6: they're on, how best to administer medications, maybe if the
- 5:59Speaker 6: patient has a tube or a GJ tube that's you know,
- 6:02Speaker 6: clogging with certain medications or certain like certain things like that,
- 6:05Speaker 6: they can really help troubleshoot those circumstances. And also, you know,
- 6:11Speaker 6: it's very helpful to have them there to help minimize
- 6:15Speaker 6: errors as well, like in terms of medication dosing and
- 6:19Speaker 6: things like that. So with that team, we also kind
- 6:25Speaker 6: of work together on different research initiatives, and so we
- 6:30Speaker 6: have worked together within our department on multiple quality improvement
- 6:35Speaker 6: projects and things like that together with clinical pharmacy to
- 6:39Speaker 6: really improve patient care. And so some examples were things
- 6:44Speaker 6: like we looked at compliance with abortive medications, so in
- 6:49Speaker 6: children with epilepsy who are having frequent, prolonged seizures, we
- 6:53Speaker 6: always provide them with a seizure action plan that helps
- 6:57Speaker 6: detail for the parents when to you is a rescue
- 7:00Speaker 6: medication and how much to give and things like that.
- 7:04Speaker 6: And several years ago, we looked at our baseline data
- 7:06Speaker 6: and saw that across the board, the aboartive medications were
- 7:11Speaker 6: not being properly prescribed in various places like the emergency room,
- 7:15Speaker 6: by primary care, by even within neurology because all of
- 7:19Speaker 6: the medications are weight based and things like that, as
- 7:23Speaker 6: patients grew, sometimes those weren't being adequately adjusted, and so
- 7:27Speaker 6: we worked with clinical pharmacy and multiple other of the
- 7:33Speaker 6: clinicians to improve compliance so that doses were being double
- 7:39Speaker 6: checked so that within our ordering system we could we
- 7:44Speaker 6: could have the dosing parameters and guidelines there and kind
- 7:49Speaker 6: of hospital wide education initiatives to help improve that. So
- 7:55Speaker 6: that that was a great project and very successful and
- 7:59Speaker 6: really helped to kind of helped patients get better care overall.
- 8:06Speaker 6: And so having clinical pharmacy involved has really been helpful
- 8:10Speaker 6: from that perspective.
- 8:12Speaker 3: Amanda, I think back to my own experience there as
- 8:15Speaker 3: part of that team and even getting to work on
- 8:17Speaker 3: some of those things alongside alongside of you and others.
- 8:20Speaker 3: It's amazing how when you bring different perspectives to the table,
- 8:24Speaker 3: new ideas happen that further patient care. And it's not
- 8:28Speaker 3: just about saving money, but it's about really helping the
- 8:33Speaker 3: patients have the highest quality care. And we've talked on
- 8:36Speaker 3: our podcast even just recently about this idea of the
- 8:40Speaker 3: quadruple aim that we're aiming for, and one of the
- 8:43Speaker 3: key ways to do that is just through in a
- 8:45Speaker 3: professional collaboration. Just to tell one brief story too, I'm
- 8:49Speaker 3: actually very grateful to Amanda herself because one of the
- 8:52Speaker 3: very first studies that I got to be a part
- 8:54Speaker 3: of publishing was looking at the use of topiramate for
- 8:58Speaker 3: the treatment of infantile spasms. And for me, I understood
- 9:02Speaker 3: the drug really well, and I had a pretty good
- 9:04Speaker 3: understanding of the condition, but by golly, I can't read
- 9:07Speaker 3: me eg And so I learned so much by collaborating
- 9:12Speaker 3: with doctor Weber and another collaborator as well, to learn
- 9:16Speaker 3: number one, how to even approach retrospective clinical research, and
- 9:21Speaker 3: then secondly to simply further my understanding of how much
- 9:26Speaker 3: it takes a real inter professional team to take great
- 9:29Speaker 3: care of kids. So I'm grateful to you, Amanda for
- 9:33Speaker 3: allowing me to be a part of that project. And
- 9:36Speaker 3: I think it's just another example of how we all
- 9:39Speaker 3: in our different fields need to be collaborating to advance
- 9:43Speaker 3: the care of the kids that are coming across our
- 9:46Speaker 3: paths and to just again care well for everyone that's there.
- 9:51Speaker 3: So yeah, thanks for all those examples. I think those
- 9:54Speaker 3: are a lot of fun even for me to reminisce about.
- 9:56Speaker 4: A little bit. Yeah. Really, it's funny we're all to
- 9:59Speaker 4: pyramid because one of my first projects collaborating with my
- 10:03Speaker 4: neurologists shout out to doctor Michelle Is was a project
- 10:06Speaker 4: on to pyramid and it was looking at to pyra
- 10:08Speaker 4: meet rectal suspensions and how we had to transition patients
- 10:12Speaker 4: over to rectual if they were like NPO and we
- 10:14Speaker 4: had no other options in the piqu for toil pyamate.
- 10:17Speaker 4: But it was like a lot of learning and that
- 10:20Speaker 4: brings you back so many memories of neurology rounds every
- 10:22Speaker 4: afternoon at two where we would look at the egs.
- 10:24Speaker 4: I'd be totally flolless, but they would see the hyps
- 10:26Speaker 4: earithmia and then it would like trigger my brain to
- 10:29Speaker 4: think of like, Okay, do we work on coordinating actch
- 10:32Speaker 4: do we do like the high dose partnicsulin protocol or
- 10:36Speaker 4: are we doing saber like is it to ersterosis? Is idiopathic?
- 10:40Speaker 4: And then all of the ideas shoot around and like
- 10:43Speaker 4: neurology rounds honestly were my favorite because it was just
- 10:45Speaker 4: the collaboration of the minds.
- 10:49Speaker 5: Yeah, that's a great, great example, Amanda.
- 10:53Speaker 3: I would love to know if you think back on
- 10:55Speaker 3: your on your training, were there any interactions you had
- 10:58Speaker 3: with pharmacists that maybe change the way you practiced. Maybe
- 11:03Speaker 3: it was how you used a certain drug or monitored
- 11:06Speaker 3: it differently, or maybe selected patients that should or should
- 11:10Speaker 3: not receive one. Are there any stories or specifics that
- 11:13Speaker 3: come to mind when you think about having a pharmacist
- 11:15Speaker 3: work with you, how it's formed your own practice.
- 11:19Speaker 5: Absolutely.
- 11:20Speaker 4: So.
- 11:20Speaker 5: There are a couple of things I can think of.
- 11:23Speaker 6: One is I worked on a project that was aiming
- 11:26Speaker 6: to improve knowledge in adolescent girls about kind of the
- 11:34Speaker 6: interactions between anti seizure medications and oral contraceptives, and also
- 11:40Speaker 6: just the importance of prescribing fulloic acid. Mostly because of
- 11:44Speaker 6: all of the potential tratogenic effects of the anti seizure medications.
- 11:49Speaker 6: And so one of my QI projects focused on kind
- 11:52Speaker 6: of improving access to fulloic acid for these patients, and
- 11:57Speaker 6: with that I learned so much from the pharmacist who
- 12:01Speaker 6: was involved, and both about anti seizure medication interactions with
- 12:06Speaker 6: oral contraceptives, which are very very confusing and there are
- 12:12Speaker 6: so many different ones, and depending which medication and which
- 12:15Speaker 6: dose you're on, it can be a lot to keep
- 12:18Speaker 6: track of. And then also just just the practicality or
- 12:24Speaker 6: just the practical aspects of prescribing fullic acid and having
- 12:29Speaker 6: patients be adherent with that. And during those projects I
- 12:34Speaker 6: had access to different pharmacy staff to help also directly
- 12:39Speaker 6: explain that to patients, which I thought was really impactful.
- 12:43Speaker 6: Sometimes just hearing it from from somebody else can be
- 12:46Speaker 6: really helpful to the patients.
- 12:50Speaker 4: Yet also just like having the pharmacist backup a lot
- 12:54Speaker 4: of times, like the neurologis would try to explain something
- 12:57Speaker 4: to the pearances and the pearential like no, no, like
- 12:59Speaker 4: I I don't, I don't believe that, and then they'll
- 13:01Speaker 4: be like, oh, but I have the drug expert, and
- 13:03Speaker 4: the drug expert will come in and then just like
- 13:05Speaker 4: having that like that person to tag team with and
- 13:08Speaker 4: like on the same token, if I'm explaining something to
- 13:10Speaker 4: a parent and having like a physician like, oh no,
- 13:13Speaker 4: I have someone to like tag keem in and also
- 13:16Speaker 4: like help me explain. I feel like that helps a
- 13:18Speaker 4: lot too. So, like things like birth control are super confusing,
- 13:21Speaker 4: Like I can't even tell you all the different doses
- 13:24Speaker 4: and products. I really always have to look them up.
- 13:27Speaker 4: But just like having that backup and having that support
- 13:29Speaker 4: is always nice.
- 13:31Speaker 6: Absolutely, And there's so many parents who are hesitant to
- 13:34Speaker 6: add another medication or to even start medication in the
- 13:37Speaker 6: first place, even for epilepsy that we have great success
- 13:41Speaker 6: in treating like childhood apps once epilepsy, and so sometimes
- 13:45Speaker 6: you know, I can talk to them at great length
- 13:47Speaker 6: about these medications and how well they're tolerated and things
- 13:50Speaker 6: like that. But just having somebody else, like you said,
- 13:53Speaker 6: to be able to come in and that is their
- 13:55Speaker 6: area of expertise, those specific medications that can really give
- 13:58Speaker 6: a different perspective to the families and really kind of
- 14:02Speaker 6: help get the patient the best treatment.
- 14:06Speaker 4: Yeah, because at the end of the day, we're a team,
- 14:08Speaker 4: and that's the most beautiful part about like medicine and
- 14:10Speaker 4: where it's going. We're all a team. We all have
- 14:13Speaker 4: our specialties, we all have our strengths in our weaknesses,
- 14:16Speaker 4: and we kind of work on and off of each
- 14:18Speaker 4: other to just provide the best care.
- 14:22Speaker 3: Absolutely, So, Amanda, I know you've practiced other places during
- 14:27Speaker 3: your career so far as well. So have you always
- 14:30Speaker 3: had a pharmacist available that maybe specializes in your area
- 14:34Speaker 3: of pediatric neurology or have you seen that that practice
- 14:37Speaker 3: varies from health system to health system.
- 14:41Speaker 5: It really varies.
- 14:42Speaker 6: So the last place I was, I was there for
- 14:45Speaker 6: almost almost eight years, seven and a half years, and
- 14:48Speaker 6: we did not have access really to clinical pharmacists except
- 14:52Speaker 6: in the ICU, and so there were so many additional
- 14:57Speaker 6: barriers unfortunately to care and and really not a single
- 15:04Speaker 6: source or a single person that I could rely on
- 15:07Speaker 6: to to help me troubleshoot or to ask these questions from.
- 15:11Speaker 5: And so some.
- 15:13Speaker 6: Of the some of the things that I remember being
- 15:16Speaker 6: especially problematic were getting approval for things like the medications
- 15:22Speaker 6: for lenox gusto, or for in patients who had failed
- 15:26Speaker 6: multiple other medications and things like that. Just getting access
- 15:30Speaker 6: to some of the newer medications was really really tough.
- 15:34Speaker 6: Or for the patients with infantile spasms who needed, you know,
- 15:38Speaker 6: to be connected with a c t H or the
- 15:41Speaker 6: REMS program for vagabatrin, the nurses were having to do
- 15:45Speaker 6: so much behind the scene work to try to get
- 15:49Speaker 6: those things done that there were really delays in in
- 15:53Speaker 6: care as a result of that, And so that was
- 15:56Speaker 6: one place that I really really missed having clinical pharmacists
- 16:01Speaker 6: within our team, was especially managing those patients.
- 16:08Speaker 4: And I mean, just thinking back in the different areas
- 16:11Speaker 4: where you've had a pharmacist in what areas do you
- 16:13Speaker 4: think pediatric pharmacists are underutilized?
- 16:18Speaker 6: So I think that I wish that they were honestly
- 16:22Speaker 6: available in every single one of our clinics, which I
- 16:25Speaker 6: know is hard.
- 16:27Speaker 4: But.
- 16:29Speaker 6: We really they just make such a positive impact when
- 16:34Speaker 6: they're there, and it's so helpful to be able to
- 16:37Speaker 6: rely on a clinical pharmacist to help with with patient
- 16:41Speaker 6: teaching and with discussions with families about side effects that
- 16:46Speaker 6: I really wish that they could somehow be integrated to
- 16:49Speaker 6: all of our general neurology clinics as well, and also
- 16:53Speaker 6: to our general neurology rounds, just to be present during
- 16:57Speaker 6: rounds like they are in the ICU. I also think
- 17:01Speaker 6: we're very lucky here at Nationwide Children's Hospital because the
- 17:05Speaker 6: pharmacists really play a role in things like prior authorizations
- 17:11Speaker 6: and helping to appeal when medications are are declined by
- 17:17Speaker 6: the insurance companies, and even just just getting rapid access
- 17:22Speaker 6: to medications that are expensive or need certain approvals. The
- 17:27Speaker 6: pharmacists really help with those things, and so I wish
- 17:32Speaker 6: that there were more of them so that we could,
- 17:35Speaker 6: you know, kind of expand some of those services.
- 17:39Speaker 3: Amanda, It's interesting I think back over the last twenty
- 17:42Speaker 3: years of my career and when I started working with
- 17:45Speaker 3: the neurology team there, I knew of probably five pediaptric
- 17:49Speaker 3: neurology pharmacists there. We're almost none of us nationwide. And now,
- 17:55Speaker 3: when you think about where pharmacy practice has gone, reallylogy
- 18:00Speaker 3: has become one of those areas that rapidly expanded in
- 18:03Speaker 3: the last ten to fifteen years, namely because of all
- 18:06Speaker 3: of these medications that you've mentioned that a have a
- 18:10Speaker 3: lot of drug interactions. They may require therapeutic drug monitoring
- 18:13Speaker 3: where we're checking levels or other things, or they have
- 18:16Speaker 3: rems programs. As you've mentioned, it's amazing how much expansion
- 18:22Speaker 3: there's been in the armamentarium we have to treat epilepsy
- 18:25Speaker 3: and other neurologic conditions, but it's meant some specialty drugs
- 18:29Speaker 3: that require a lot more effort and a lot more oversight.
- 18:33Speaker 3: So it's fun to me to hear that, yes, there
- 18:37Speaker 3: is a lot of opportunity for growth, but it's also
- 18:40Speaker 3: exciting to think through that there has been that growth,
- 18:43Speaker 3: and I think that trajectory hopefully will continue moving forward. Well,
- 18:48Speaker 3: we also wanted to ask are there any just cool
- 18:51Speaker 3: lessons that you feel like you learned from a pediatric
- 18:53Speaker 3: clinical pharmacist, whether it was in your training or maybe
- 18:56Speaker 3: another part of your career.
- 18:59Speaker 6: Yes, So some of the most important things I think
- 19:03Speaker 6: that I've learned I work sometimes in the ketogenic diet clinic,
- 19:07Speaker 6: and so learning about the carbohydrate concentrations and drugs that
- 19:11Speaker 6: stuff can be really hard to track down. But I've
- 19:14Speaker 6: learned so much from our clinical pharmacists about different medications
- 19:20Speaker 6: in the context of ketogenic diet, and.
- 19:24Speaker 5: So that's one.
- 19:25Speaker 6: The other thing that I distinctly remember is there were
- 19:30Speaker 6: different taste testing and justin I can't remember if you
- 19:33Speaker 6: did this, I think you did, but just having the
- 19:36Speaker 6: ability I remember on the id floor tasting different antibiotics
- 19:40Speaker 6: that were, you know, just so that we could see
- 19:42Speaker 6: what the patients were experiencing and why they were spitting
- 19:45Speaker 6: it out and things like that. And I believe you
- 19:47Speaker 6: did that with anti seizure medications too, but I for
- 19:50Speaker 6: whatever reason, missed it that.
- 19:52Speaker 5: But that's that's one of.
- 19:53Speaker 6: The funniest, the coolest things that I guess I remember
- 19:57Speaker 6: being taught by you.
- 19:58Speaker 4: Yeah, when I did that for my residence, I actually
- 20:02Speaker 4: made it like a wine tasting, so I had like
- 20:04Speaker 4: a scoring sheet and we played classical music and I
- 20:07Speaker 4: just had it all set up with like cheese and crackers,
- 20:10Speaker 4: and they got such a kick out of it. But
- 20:13Speaker 4: some of them didn't realize that we had a little
- 20:16Speaker 4: bit of flagile. So then later that night, like they
- 20:18Speaker 4: had a glass of wine or something, and the next
- 20:20Speaker 4: day they were like, Okay, lesson learned, never ever ever
- 20:23Speaker 4: mixing metronitis ale with alcohol ever again.
- 20:27Speaker 3: Oh, Mary, You're way more creative than I am on that.
- 20:29Speaker 3: That's an unforgettable experience right there. That's great.
- 20:32Speaker 4: And then in Amanda, in your perfect world, where would
- 20:35Speaker 4: you integrate a pediatric clinical pharmacist to your care team.
- 20:38Speaker 4: I feel like my wish list for this is like
- 20:41Speaker 4: one of the hospitals here, each physician has their own
- 20:43Speaker 4: personal pharmacist and it's a cancer institute, so I totally
- 20:47Speaker 4: get that. But that would be like ideal for me
- 20:50Speaker 4: to just be like a physician's buddy that just like
- 20:53Speaker 4: you work hand in hand together in a clinic together
- 20:55Speaker 4: on the floor, like how most physicians have like the
- 20:58Speaker 4: nurse practitioner. But what's your ideal like cheatric pharmcist arrangement.
- 21:03Speaker 6: Oh, that would be amazing if we could have, that
- 21:06Speaker 6: would be absolutely amazing. But you know, another thing that
- 21:09Speaker 6: I think would be really helpful would be to have
- 21:11Speaker 6: a clinical pharmacist kind of generally assigned to specific patients,
- 21:17Speaker 6: or have patients just like they have just like a
- 21:21Speaker 6: patient would have a primary neurologist, if they had a
- 21:24Speaker 6: primary clinical pharmacist that they could directly ask questions and
- 21:28Speaker 6: send my chart messages to and things like that, I
- 21:31Speaker 6: think that that would be really helpful, and that way
- 21:36Speaker 6: the pharmacist could know the family, the family could have
- 21:39Speaker 6: a direct contact point, and we could also then as
- 21:44Speaker 6: providers or as physicians. We would also know who to
- 21:48Speaker 6: specifically direct questions to about those patients. And I guess
- 21:52Speaker 6: it doesn't make sense practically for every single patient probably
- 21:56Speaker 6: to have a clinical pharmacist, but you know, maybe maybe
- 22:01Speaker 6: specific populations of patients, like all of the Lenox gusto
- 22:05Speaker 6: patients kind of are generally overseen by a couple of
- 22:09Speaker 6: pharmacists or something like that. I think that that would
- 22:11Speaker 6: be really ideal, but again ideal world.
- 22:16Speaker 4: That's kind of our goal right now at perfecting PEDS
- 22:19Speaker 4: because we are attributed through like the health plan, and
- 22:21Speaker 4: we do have our set patients. It's nice. It's nice
- 22:25Speaker 4: building the relationships. So whenever we do see these parents,
- 22:28Speaker 4: it's like seeing an old friend like oh, hey, you
- 22:30Speaker 4: got a haircut, or like how is your vacation? And
- 22:32Speaker 4: then you have that pharmacist that like knows that child
- 22:35Speaker 4: really well. So it's coming hopefully for the whole nation.
- 22:40Speaker 4: We're in Minnesota and Pennsylvania for now.
- 22:44Speaker 5: Oh that's great to hear.
- 22:46Speaker 3: Yeah, and I'll just second that idea. When you think
- 22:51Speaker 3: about especially in your practice, Amanda of PEDS neurology, most
- 22:55Speaker 3: kids with medical complexity are going to have some type
- 22:59Speaker 3: of either or logic or sometimes behavioral comorbidity, but neurology
- 23:04Speaker 3: comorbidities are just so so prevalent in that population, and
- 23:09Speaker 3: so to me, that seems like a very natural place
- 23:13Speaker 3: for pharmacists to be more involved. Whether it's just like
- 23:16Speaker 3: you said, be available, right, Maybe a pharmacist doesn't need
- 23:19Speaker 3: to see all of these patients, but can they be
- 23:22Speaker 3: available for those who really have questions and where it
- 23:26Speaker 3: would be helpful?
- 23:27Speaker 5: Absolutely, Amanda.
- 23:29Speaker 3: One other thing that I know that a lot of
- 23:32Speaker 3: pharmacists will be involved in is the development of clinical
- 23:36Speaker 3: pathways or different protocols that an institution might follow. And
- 23:41Speaker 3: again that's a collaborative effort, right, that's not just a
- 23:44Speaker 3: pharmacist effort. But tell me, is that something that you
- 23:47Speaker 3: have seen in your practice.
- 23:50Speaker 5: Absolutely so.
- 23:51Speaker 6: One of the most recent projects I've been involved with
- 23:54Speaker 6: is the treatment of status epilepticus within our hospital and
- 23:58Speaker 6: so around that we have had multidisciplinary teams working on
- 24:05Speaker 6: decreasing the length of time to abortive medication administration within
- 24:10Speaker 6: the hospital. So when there's a seizure that occurs within
- 24:13Speaker 6: the hospital, how can we most quickly get the patients
- 24:16Speaker 6: their first line benzodiazepine medication, and so doctor Ostendorf from
- 24:21Speaker 6: Nationwide Children's Hospital kind of headed up a quality improvement
- 24:25Speaker 6: project that required a lot of support from pharmacy and
- 24:29Speaker 6: that kind of gathered some baseline data that on average,
- 24:33Speaker 6: it was taking about fourteen minutes to get patients their
- 24:36Speaker 6: first line medication from the time of the onset of seizure.
- 24:40Speaker 6: And so they really changed the way that our hospital
- 24:44Speaker 6: that practice happens at our hospital in that previously there
- 24:49Speaker 6: was intramuscular or IV medication that was given and now
- 24:54Speaker 6: just about across the entire hospital, all of the nurses
- 24:58Speaker 6: have been trained to use intrnasal medazolam first line and
- 25:05Speaker 6: through various teaching initiatives. It required all kinds of rehaul
- 25:10Speaker 6: in terms of the the way that that providers are
- 25:15Speaker 6: entering orders, how order sets look, where medication is stored,
- 25:21Speaker 6: you know, the training initiatives, all of those things had
- 25:23Speaker 6: to come together. But it's resulted in a pretty dramatic
- 25:27Speaker 6: improvement and care. And so now the average time to
- 25:31Speaker 6: first medication is about seven and a half minutes, so
- 25:35Speaker 6: almost almost cut in half. So that was a place
- 25:38Speaker 6: that that I know that pharmacy was very involved and
- 25:41Speaker 6: very helpful and kind of along the same, along the
- 25:46Speaker 6: same thought process.
- 25:47Speaker 5: Our status protocol in general.
- 25:50Speaker 6: Is being revamped and and we've really utilized our clinical
- 25:56Speaker 6: pharmacists to help us, to help us which medications to
- 26:01Speaker 6: use first line after benzodiazepines fail. So we are in
- 26:07Speaker 6: the process of rolling out to most of the floors
- 26:09Speaker 6: now utilizing levitre actam first line.
- 26:13Speaker 5: But to be able to do.
- 26:14Speaker 6: That, we've had to change what is in the pixis
- 26:19Speaker 6: and you know, notify everybody, change all of the order sets,
- 26:23Speaker 6: and so pharmacy has been very, very involved in that
- 26:27Speaker 6: whole process and ultimately it's it's resulting in better patient
- 26:32Speaker 6: care obviously, which is the most important thing.
- 26:37Speaker 4: Yeah, I remember working on like the status protocols and
- 26:41Speaker 4: like figuring out the pump settings and all that stuff.
- 26:44Speaker 4: So it's fun working together and like having the ideas
- 26:47Speaker 4: and working together on clinical pathways because we think that
- 26:50Speaker 4: a pathway is something so simple, but it takes so
- 26:53Speaker 4: much teamwork. So it takes like the brainstorming between the
- 26:56Speaker 4: multidiscplinary team of like physicians, pharmacists, nurses, but then it
- 27:00Speaker 4: takes the the pharmacists to program everything and if they
- 27:02Speaker 4: figure out logistics the nurses to educate on an administration
- 27:06Speaker 4: and process changes. So it really takes a whole village
- 27:09Speaker 4: when it comes to things like clinical pathways.
- 27:12Speaker 5: That's true.
- 27:15Speaker 3: Well, Amanda, at the end of this episode, we wanted
- 27:18Speaker 3: to maybe flip the tables a little bit and see
- 27:21Speaker 3: do you have any questions for us as a pediatric
- 27:24Speaker 3: pharmacist and maybe about our interactions with physicians and others
- 27:30Speaker 3: on the healthcare team.
- 27:32Speaker 6: I would love to hear how interacting with us and
- 27:36Speaker 6: how interacting with medical residents and the healthcare team has
- 27:41Speaker 6: shaped and changed your practice.
- 27:46Speaker 3: Well, that's a great question. I could jump right on it,
- 27:50Speaker 3: But Mary, do you have anything that you would say
- 27:52Speaker 3: to start?
- 27:54Speaker 4: Well, I have this bad trait of just becoming best
- 27:57Speaker 4: friends with everybody and just wanting everyone to be my friend.
- 28:00Speaker 4: So that was like one of the biggest sources of
- 28:03Speaker 4: like friendships for me in the hospital was through the
- 28:05Speaker 4: medical residence and the physicians and a lot of them
- 28:09Speaker 4: we started off as friends during like during residency together
- 28:12Speaker 4: and we would grow on and they would stay on
- 28:15Speaker 4: as attendings. I would stay on as a pharmacist, and
- 28:17Speaker 4: it was just nice like working with your friends and
- 28:20Speaker 4: just like rounding with your friends and just having that
- 28:22Speaker 4: relationship where you trust each other and it would be like, oh,
- 28:25Speaker 4: whatever Mary says, like we can do that to the dose.
- 28:27Speaker 4: And it was nice having that like really collaborative relationship
- 28:31Speaker 4: with them. But then my other favorite thing was just learning.
- 28:33Speaker 4: Like I learned that when you take an ammonia level,
- 28:36Speaker 4: it has to be like put on ice, very specific.
- 28:38Speaker 4: You can't shake it, like you have to literally walk
- 28:40Speaker 4: it straight to the lab. And that was like one
- 28:42Speaker 4: of them was profound things I learned from the residence,
- 28:45Speaker 4: But just like learning all the little medical tidbits and
- 28:48Speaker 4: just like learning together I think was one of the
- 28:50Speaker 4: greatest things because it just really opened the floor to
- 28:53Speaker 4: being just the collaborative place where like nobody is telling
- 28:57Speaker 4: each other what to do, or like learning together, just
- 29:00Speaker 4: like trying to progress with the care.
- 29:04Speaker 3: Yeah, I love those aspects And for me, I think
- 29:07Speaker 3: remembering being on rounds in the pick you when I
- 29:11Speaker 3: was first training. I loved learning about the nuances of
- 29:19Speaker 3: differential diagnosis and trying to figure out what's going on
- 29:21Speaker 3: with a patient. And the reason why that was so
- 29:24Speaker 3: helpful for me is as a pharmacist, my job was
- 29:26Speaker 3: to discern are there any drug related problems that may
- 29:29Speaker 3: be at play here. But I, over time, learning from
- 29:34Speaker 3: the residents and from the physicians I worked with, got
- 29:37Speaker 3: even better at discerning well, but there are other possibilities
- 29:40Speaker 3: and maybe there are other people that need to look
- 29:42Speaker 3: at this beyond just my thought that it's a drug
- 29:45Speaker 3: side effect, especially again we're going back to antipeleptics, but
- 29:49Speaker 3: sedation and the ICU and all the various things that
- 29:53Speaker 3: we give, there can be so many factors at play
- 29:56Speaker 3: that may be impacting a patient's status. Beyond, of course,
- 30:00Speaker 3: are the drugs. And so I just loved that problem
- 30:05Speaker 3: solving process that residence showed me is so important. It's
- 30:11Speaker 3: it's art and it's science. It's good listening to your
- 30:14Speaker 3: patients and your families. It's also knowing the diagnostic tools
- 30:18Speaker 3: that you have available to make the best assessments for
- 30:21Speaker 3: your patient. And ultimately we've got to do that well
- 30:24Speaker 3: and if we're going to know how to treat well.
- 30:26Speaker 3: So for me, it just opened my eyes to how
- 30:30Speaker 3: important that diagnostic process is not only to getting to
- 30:37Speaker 3: a cause for what's going on, but then guiding our treatment.
- 30:41Speaker 3: For me, I nerded out on EGS. I can't read
- 30:45Speaker 3: any EG. Still today, I don't have that training right,
- 30:47Speaker 3: but I love going to the EEG room after rounds
- 30:52Speaker 3: and looking for those spike and wave discharges and understanding
- 30:56Speaker 3: what delta activity is versus something else. And I think
- 31:00Speaker 3: Mary brought up the idea of hipsteridmy and seeing that
- 31:02Speaker 3: and some of our infantile spasms patients, and so for me,
- 31:05Speaker 3: even understanding the mapping of the different montages of an
- 31:09Speaker 3: EG was enlightening and just fun. It was fun to
- 31:13Speaker 3: learn even just a tiny bit about it. So yeah,
- 31:17Speaker 3: I think for me the biggest thing was enjoying learning
- 31:20Speaker 3: the relationships, but also appreciating the skill with which physicians
- 31:27Speaker 3: and others are diagnosing patients and how that plays into
- 31:30Speaker 3: their care.
- 31:31Speaker 4: I totally agree with you. I think learning all of
- 31:33Speaker 4: the diagnostic implications really made me a better pharmacist because
- 31:37Speaker 4: it made me more creative. It made me think, like, Okay,
- 31:39Speaker 4: it's not just this, it could be so many other things.
- 31:42Speaker 4: And I only know that because I listened in on
- 31:44Speaker 4: rounds and I heard the differential and then I saw
- 31:47Speaker 4: the symptoms and it all ties together. So it kind
- 31:49Speaker 4: of just all like shoots into your brain. But then I, like,
- 31:53Speaker 4: I tell my students. I'm like, one day you'll pull
- 31:55Speaker 4: it out because you'll think of something, it'll connect, and
- 31:58Speaker 4: then it'll somehow work out. I think another thing on
- 32:02Speaker 4: a personal level that I loved with seeing and working
- 32:04Speaker 4: with the medical residence is learning resiliency because the training
- 32:08Speaker 4: is so intense. Just the residency itself is intense. Some
- 32:12Speaker 4: days on the floor are just an intense and just
- 32:14Speaker 4: the fact that they're able to carry so many patients
- 32:17Speaker 4: still do a stellar job and still keep their sanity
- 32:21Speaker 4: was always great. Like I would always look at them
- 32:23Speaker 4: and like, Okay, they're surviving, like I can survive. And
- 32:25Speaker 4: I would always look to them as a beacon of hope, like, Okay,
- 32:28Speaker 4: we'll make it through. Like it's a hard week, but
- 32:30Speaker 4: like they have it much harder, they can push through.
- 32:32Speaker 4: We can all push through together.
- 32:34Speaker 6: I definitely felt that too, that as a team, we
- 32:37Speaker 6: all lean on each other even still day to day.
- 32:40Speaker 4: Yeah.
- 32:41Speaker 3: Well, Amanda, it's been a pleasure, first of all, just
- 32:43Speaker 3: to catch up. You're doing great, and I love hearing
- 32:47Speaker 3: that you're doing great things still being back at Nation
- 32:49Speaker 3: my children's We appreciate you coming on the podcast today.
- 32:52Speaker 3: It's just been an absolute pleasure.
- 32:53Speaker 5: Thank you so much.
- 32:54Speaker 2: That's all for today's episode. Thanks for listening, and remember
- 32:58Speaker 2: to subscribe on Apple Podcasts and leave us a review.